Ronald King

A new 'RaiseWell Certified' label for beef just launched, promising total traceability and higher ethical standards. But will it finally clear up consumer confusion?

With major clinical trials, including a novel approach for Alzheimer's, and key market access wins, MMI's Symani system is poised to redefine microsurgery.

A new partnership between Second Front Systems and Paramify leverages automation to slash software compliance times from years to months for government agencies.

In 2025, A&G saved retailers like Rite Aid and expanded its expertise to healthcare and life sciences, showcasing the power of strategic real estate.

The FinTech firm's multiple 'Best Places to Work' honors highlight a key strategy for winning the fierce competition for top AI and technology talent.

Elevest Capital acquires a 240-unit complex, signaling a strategic push to modernize older assets amid Charlotte's record construction and shifting rents.

Priestly Demolition appoints an external CEO and promotes internal leaders, a strategic move to blend new expertise with its family legacy for major expansion.

Circle Pharma will unveil its pipeline of novel oral macrocycle drugs targeting elusive cancer drivers at the influential J.P. Morgan Healthcare Conference.

EMERGE Commerce CEO Ghassan Halazon unveils a new strategy, detailing past growth errors and a multi-year turnaround that pivots the firm to disciplined growth.

The acquisition of seven Kloeckner service centers marks a major strategic push, expanding Russel Metals' U.S. footprint and value-added capabilities.

Nouveau Monde Graphite issues stock to pay interest to its major investor, Investissement Québec, highlighting a strategy to conserve cash for key projects.

With CEO David Endicott set to present at the J.P. Morgan Healthcare Conference, all eyes are on Alcon's strategy for innovation and market growth.

The Avista Foundation's latest grants empower 76 non-profits across five states, fueling vital arts, culture, and environmental stewardship projects.

At CES 2026, 3M unveils AI tools that let engineers digitally design and test materials that don't even exist yet, slashing R&D time and cost.

Swapping fireworks for a star-studded music and light show, Hong Kong's New Year's countdown is a strategic bid to reignite global tourism.

As its cash runway shortens, Longeveron's novel stem cell therapy gets a major boost with selection for a prestigious Alzheimer's health moonshot.

A new toothbrush using safe microcurrents claims to remove 6x more plaque and cut gum inflammation. Does the science behind this oral care revolution hold up?

The cleantech firm hits key milestones in German and Italian energy projects while its unconventional portfolio expands into biotech and agritech.

A major acquisition turned sour, a 25% stock crash, and now a class action lawsuit. Inside Perrigo's costly infant formula venture and what it means.

The U.S. government is partnering with 24 tech leaders, including Accenture, on a mission to double R&D and secure global leadership in AI.